$NRX Pharmaceuticals Inc.(NRXP)$
As we wait patiently FDA approval. ⬇️
"To our knowledge this is the first demonstration of clinically and statistically-significant benefit by any therapeutic agent in patients with COVID-19 respiratory failure in a randomized, double blind, prospective trial….. ZYESAMI, if authorized, would be the first drug for such critically ill patients. $nrxp
精彩评论